Dr Weng
Chief Executive Officer
Ergomed
Ergomed
Russian Federation
Biography
Dr Weng joined Ergomed as CEO in July 2017 after six years at EPS International Holding Co., where he was Chairman, President and CEO. During his tenure, Dan oversaw significant growth, both organically and through M&A in Asia, the US and Europe, with revenues increasing over five-fold. He was also a Board Director of EPS Holdings, Inc., a global CRO listed on the Tokyo Stock Exchange Prior to this, Dan delivered growth in executive positions at international CROs including MedPace, Icon Clinical Research, PharmaNet and Quintiles, for over 20 years. His background covers multiple therapeutic areas, supporting all stages of development through to approval. Dan qualified as a medical doctor at Tongji Medical University, China, and holds an MA in Health Planning, Policy and Management from the University of Leeds, UK. He also held research positions at Harvard Medical School – Massachusetts General Hospital and the University of California.
Research Interest
Health Planning
